by Bruce Sylvester – A new meta-analysis of clinical trials evaluating the use of statin medications to prevent heart attacks suggests that the drugs do not threaten short-term… read more.
Taken from the Pain in Europe VIII – 8th EFIC Congress held from 9–12 October 2013, Florence.
Taken from the Pain in Europe VIII – 8th EFIC Congress held from 9–12 October 2013, Florence.
Taken from the Pain in Europe VIII – 8th EFIC Congress held from 9–12 October 2013, Florence.
Taken from the Pain in Europe VIII – 8th EFIC Congress held from 9–12 October 2013, Florence.
In part, women and men differ from each other considerably not only in the way they perceive and cope with pain and in various comorbidities. Therapies can also… read more.
Chronic obstructive pulmonary disease (COPD) is associated with an increased risk of developing cerebral microbleeds, according to a new study. Cerebral microbleeds are a marker of cerebral small… read more.
Taken from the Pain in Europe VIII – 8th EFIC Congress held from 9–12 October 2013, Florence.
Taken from the Pain in Europe VIII – 8th EFIC Congress held from 9–12 October 2013, Florence.
Video Interview from the Pain in Europe VIII – 8th EFIC Congress held from 9–12 October 2013, Florence.
Bernhard Banas, Regensburg, Germany – Prolonged-release tacrolimus administered once-daily provides high rates of graft survival and reduction in biopsy-confirmed acute rejection (BCAR), with a manageable tolerability profile, in… read more.
by Pavel Trunečka, Prague, Czech Republic – Starting on a low dose of prolonged-release, once-daily tacrolimus after liver transplantation achieved better renal function and a significantly lower risk… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
